Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Undergraduate: Mobility, musculoskeletal health and arthritis - ICS

University of Toronto

$5,000.00

The differentiation state of myofibroblasts controls direct binding of macrophages

FY 2013-14

Summary
Of one million silicone pads that are implanted worldwide for aesthetic and reconstructive breast surgeries each year, 20-30% require recursive operations due to encapsulating fibrotic reactions. Fibrotic capsules develop as a consequence of fibroblast-to-myofibroblast activation at the surface of the implant. Fibrosis is the accumulation of collagen-rich and stiff extracellular matrix in response to tissue injury and chronic inflammation. The stiffness of the implant (from the cell's point of view) and of fibrotic tissues continuously activate normal connective tissue cells (fibroblasts) into highly contractile myofibroblasts. In turn, enhanced myofibroblast contraction produces more non-functional collagen scar tissue that impedes implant function and causes severe esthetic problems. Based on previous observations in the Hinz lab, we hypothesize that the direct interaction between myofibroblasts and inflammatory cells (macrophages) contributes to the persistence of myofibroblasts and prevents the resolution of scar tissue. The aim of this study is to evaluate whether and how inflammatory cell binding can modulate myofibroblast differentiation and contractile function. The research priority areas directly relevant to this proposal are 'Tissue Injury, Repair and Replacement' and 'Chronic Disease'. Fibrosis is a major burden for the Canadian Health Care System. It is estimated that 60-70% of all disease-related deaths are ultimately caused by fibrosis-related organ failure. To date, no therapy is effective to treat fibrosis. Long term benefits of the proposed research will be improved health of Canadians who are impacted by fibrosis, and recipients of implants and regenerative cell therapy. The understanding of cell regulation gained from this research is crucial for the rational design of more efficient therapies for fibrocontractive diseases, in particular, anti-fibrosis therapies may need to be tuned with the progress of fibrosis in different organs.
Program
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
303309
Name
Bertucci Virginia J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Undergraduate: Mobility, musculoskeletal health & arthritis - IMHA
Projecttitle
The differentiation state of myofibroblasts controls direct binding of macrophages
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$5,000
Cihrequipment2
$0
Programname2
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Keyworddelim
Chronic Inflammation; Fibrosis; Macrophages; Myofibroblast; Tissue Repair
Abstract
Of one million silicone pads that are implanted worldwide for aesthetic and reconstructive breast surgeries each year, 20-30% require recursive operations due to encapsulating fibrotic reactions. Fibrotic capsules develop as a consequence of fibroblast-to-myofibroblast activation at the surface of the implant. Fibrosis is the accumulation of collagen-rich and stiff extracellular matrix in response to tissue injury and chronic inflammation. The stiffness of the implant (from the cell's point of view) and of fibrotic tissues continuously activate normal connective tissue cells (fibroblasts) into highly contractile myofibroblasts. In turn, enhanced myofibroblast contraction produces more non-functional collagen scar tissue that impedes implant function and causes severe esthetic problems. Based on previous observations in the Hinz lab, we hypothesize that the direct interaction between myofibroblasts and inflammatory cells (macrophages) contributes to the persistence of myofibroblasts and prevents the resolution of scar tissue. The aim of this study is to evaluate whether and how inflammatory cell binding can modulate myofibroblast differentiation and contractile function. The research priority areas directly relevant to this proposal are 'Tissue Injury, Repair and Replacement' and 'Chronic Disease'. Fibrosis is a major burden for the Canadian Health Care System. It is estimated that 60-70% of all disease-related deaths are ultimately caused by fibrosis-related organ failure. To date, no therapy is effective to treat fibrosis. Long term benefits of the proposed research will be improved health of Canadians who are impacted by fibrosis, and recipients of implants and regenerative cell therapy. The understanding of cell regulation gained from this research is crucial for the rational design of more efficient therapies for fibrocontractive diseases, in particular, anti-fibrosis therapies may need to be tuned with the progress of fibrosis in different organs.
Competitiondate
201401
Approvedterm2
0 yr 3 mths
Pinamesdelim
Bertucci, Virginia J
Approvedterm
0 an 3 mois
Cihrcontribution2
~ $5,000~ $0~